Clinical Trial Update: Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency [NA]

View source ↗

Summary

This clinical trial comparing Secretin-enhanced MRCP with Endoscopic Pancreatic Function Test for diagnosing pancreatic exocrine insufficiency has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Secretin (secretin)

Snippet

Sponsor: Columbia University | Conditions: Pancreatic Cancer | NA | Status: WITHDRAWN